Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-11-2021 | Human Immunodeficiency Virus | Case report

Glecaprevir/pibrentasvir

Virological failure: 21 case reports

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Zarebska-Michaluk D, et al. Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?. Journal of Gastroenterology and Hepatology 36: 1944-1952, No. 7, Jul 2021. Available from: URL: http://doi.org/10.1111/jgh.15337 Zarebska-Michaluk D, et al. Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?. Journal of Gastroenterology and Hepatology 36: 1944-1952, No. 7, Jul 2021. Available from: URL: http://​doi.​org/​10.​1111/​jgh.​15337
Metadata
Title
Glecaprevir/pibrentasvir
Virological failure: 21 case reports
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06135-z

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Dapagliflozin